Latest Breaking News On - Global healthcare company contributing - Page 2 : comparemela.com

American Regent® Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)

American Regent® Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkDaiichi sankyoJoann gioiaLabs incCustomer support groupDaiichi sankyo groupSustainable development of societyAmerican regent incPrnewswire american regent incInnovative global healthcare companyPaclitaxel protein bound particlesInjectable suspensionAlbumin bound paclitaxelVice presidentChief commercial officer

Quizartinib NDA Review for Patients with Newly Diagnosed FLT3-ITD Positive AML Extended by FDA

Quizartinib NDA Review for Patients with Newly Diagnosed FLT3-ITD Positive AML Extended by FDA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKoji ogiwaraDaiichi sankyoMark rutsteinJennifer brennanDaiichi sankyo incDrug administrationSustainable development of societyUniversity of texas md anderson cancer centerAmerican cancer societyDaiichi sankyo co ltdOncology clinical developmentInnovative global healthcare companyNational cancer instituteEuropean hematology associationNew drug application

Daiichi Sankyo : Quizartinib NDA Review for Patients with Newly Diagnosed FLT3-ITD Positive AML Extended by FDA(219 5KB

Press Release Quizartinib NDA Review for Patients with Newly Diagnosed FLT3- ITD Positive AML Extended by FDA Tokyo and Basking Ridge, NJ - . | April 20, 2023

United statesMark rutsteinKoji ogiwaraDaiichi sankyoJennifer brennanInnovative global healthcare companyDaiichi sankyo incDaiichi sankyo co ltdDrug administrationUniversity of texas md anderson cancer centerSustainable development of societyOncology clinical developmentEuropean hematology associationPress releaseNewly diagnosedBasking ridge

American Regent introduces FDA-approved Epinephrine Injection, USP

/PRNewswire/ American Regent announces the launch of sulfite-free Epinephrine Injection, USP.1 Epinephrine Injection, USP, is indicated for emergency.

United statesNew yorkDaiichi sankyoJoann gioiaDaiichi sankyo groupAmerican regent incSustainable development of societyCustomer support groupInnovative global healthcare companyVice presidentChief commercial officerAmerican regentEpinephrine injectionImportant safety informationFull prescribingFull prescribing information

Patritumab Deruxtecan Continues to Show Encouraging Clinical Activity in Distinct Patient Populations with Metastatic Lung and Breast Cancer in Updated Results of Two Early Trials

Patritumab Deruxtecan Continues to Show Encouraging Clinical Activity in Distinct Patient Populations with Metastatic Lung and Breast Cancer in Updated Results of Two Early Trials
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHiroji iwataPatritumab deruxtecanMark rutsteinKoji ogiwaraDaiichi sankyoJennifer brennanHidetoshi hayashiDepartment of medical oncology at kindai universityJapanese society of medical oncologyDaiichi sankyo incDrug administrationSustainable development of societyDaiichi sankyo co ltdOncology clinical developmentAichi cancer center hospital